Try our beta test site

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

This study has been completed.
Sponsor:
Collaborators:
Naturalpha
Premier Research Group plc
Information provided by (Responsible Party):
Genfit
ClinicalTrials.gov Identifier:
NCT01694849
First received: September 24, 2012
Last updated: January 13, 2016
Last verified: January 2016